DAVID KUN HO JUNG, DPT
Physical Therapy at 56 St, New York, NY
License number
New York 042140-1
Category
Restorative Service Providers
Type
Physical Therapist
Address
Address
120 E 56Th St RM 1010, New York, NY 10022
Phone
(212) 759-2211
Personal information
See more information about DAVID KUN HO JUNG at radaris.comName
Address
Phone
430 E 6Th St APT 16D, New York, NY 10009
4119 249Th St, Little Neck, NY 11363
39 Wallace Rd, Binghamton, NY 13905
454 W 46Th St APT 6BS, New York, NY 10036
3909 48Th Ave, Sunnyside, NY 11104
Professional information
See more information about DAVID KUN HO JUNG at trustoria.com
Chief Financial Officer Hospital Finance At Suny Downstate Medical Center
Chief Financial Officer Hospital Finance At Suny Downstate Medical Center
Position:
Chief Financial Officer Hospital Finance at SUNY Downstate Medical Center
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Work:
SUNY Downstate Medical Center
since Mar 2012
-
Chief Financial Officer Hospital Finance
Columbia University Medical Center
Jan 2010 - Jun 2011
-
Associate Vice Dean - Finance/CFO
University of Chicago Medical Center
Jun 1998 - Jan 2010
-
Vice President for Finance
NYU Medical Center
1984 - 1998
-
Director, Budget & Planning
Education:
The University of Chicago - Booth School of Business 2004 - 2004
Certificate, Chicago Management Institute Baruch College CUNY - Mount Sinai School of Medicine 1978 - 1980
MBA, Health Care Administration Cornell University 1974 - 1978
BA, Economics
Certificate, Chicago Management Institute Baruch College CUNY - Mount Sinai School of Medicine 1978 - 1980
MBA, Health Care Administration Cornell University 1974 - 1978
BA, Economics
Skills:
Healthcare Management, Healthcare, Hospitals, Revenue Cycle, EMR, Healthcare Information Technology, Managed Care, HIPAA, Leadership, Finance, EHR, Leadership Development, Budgets, Performance Improvement, Healthcare Consulting, Informatics, Physicians, Physician Relations, Team Building, Process Improvement, Epic Systems, Quality Improvement, Revenue Cycle Management, Healthcare Industry, Medicare, Medicaid, Practice Management, Ambulatory, Patient Safety
Consultant At Kurt Salmon
Consultant At Kurt Salmon
Position:
Consultant at Kurt Salmon
Location:
Greater New York City Area
Industry:
Management Consulting
Work:
Kurt Salmon
- Greater New York City Area since Aug 2012
-
Consultant
Macquarie Group
- Greater New York City Area Jun 2011 - Aug 2011
-
Summer Analyst
Education:
Cornell University 2008 - 2012
Glycolipids And Analogues Thereof As Antigens For Nk T Cells
Glycolipids And Analogues Thereof As Antigens For Nk T Cells
US Patent:
2009023, Sep 17, 2009
Filed:
Feb 18, 2009
Appl. No.:
12/388415
Inventors:
Moriya TSUJI - New York NY, US
David D. Ho - New York NY, US
Doug Wu - San Diego CA, US
Masakazu Fujio - Yokohama, JP
David D. Ho - New York NY, US
Doug Wu - San Diego CA, US
Masakazu Fujio - Yokohama, JP
Assignee:
The Rockefeller University - New York NY
The Scripps Research Institute - La Jolla CA
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 31/7004, C07H 15/04, A61P 37/02
US Classification:
514 25, 536 179
Abstract:
This invention relates to immunogenic compounds which may serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
US Patent:
7923013, Apr 12, 2011
Filed:
Apr 13, 2007
Appl. No.:
11/735313
Inventors:
Moriya Tsuji - New York NY, US
David D. Ho - New York NY, US
Douglass Wu - San Diego CA, US
Masakazu Fujio - San Diego CA, US
Xiangming Li - Elmhurst NY, US
David D. Ho - New York NY, US
Douglass Wu - San Diego CA, US
Masakazu Fujio - San Diego CA, US
Xiangming Li - Elmhurst NY, US
Assignee:
The Rockefeller University - New York NY
The Scripps Research Institute - La Jolla CA
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/00, C07H 17/02
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
US Patent:
8586051, Nov 19, 2013
Filed:
Mar 15, 2012
Appl. No.:
13/420738
Inventors:
Moriya Tsuji - New York NY, US
David D. Ho - New York NY, US
Douglass Wu - San Diego CA, US
Masakazu Fujio - San Diego CA, US
Xiangming Li - Elmhurst NY, US
David D. Ho - New York NY, US
Douglass Wu - San Diego CA, US
Masakazu Fujio - San Diego CA, US
Xiangming Li - Elmhurst NY, US
Assignee:
The Rockefeller University - New York NY
The Scripps Research Institute - La Jolla CA
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/00
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Hazmat Specialist At Dep
Hazmat Specialist At Dep
Position:
HAZMAT SPECIALIST at DEP
Location:
Greater New York City Area
Industry:
Environmental Services
Work:
DEP
-
HAZMAT SPECIALIST
Flu Vaccines And Methods Of Use Thereof
Flu Vaccines And Methods Of Use Thereof
US Patent:
7981428, Jul 19, 2011
Filed:
Apr 2, 2009
Appl. No.:
12/417556
Inventors:
David D. Ho - New York NY, US
Yaoxing Huang - Brooklyn NY, US
Ting-Jen R. Cheng - Taipei, TW
Ming Wei Chen - NanKang, TW
Alice Yu - La Jolla CA, US
Yaoxing Huang - Brooklyn NY, US
Ting-Jen R. Cheng - Taipei, TW
Ming Wei Chen - NanKang, TW
Alice Yu - La Jolla CA, US
Assignee:
Academia Sinica - Taipei
The Rockefeller University - New York NY
The Rockefeller University - New York NY
International Classification:
A61K 39/145, A61K 48/00, C12N 15/44, C12N 7/00
US Classification:
4241861, 4242101, 514 44 R, 536 2372, 4352351, 4353201
Abstract:
This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.